149 related articles for article (PubMed ID: 34234858)
1. TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway.
Zhao X; Chen Q; Cai Y; Chen D; Bei M; Dong H; Xu J
J Cancer; 2021; 12(16):4883-4890. PubMed ID: 34234858
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m
Bei M; Hao S; Lin K; Chen Q; Cai Y; Zhao X; Jiang L; Lin L; Dong G; Xu J
Cancer Sci; 2023 Aug; 114(8):3216-3229. PubMed ID: 37317053
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
[TBL] [Abstract][Full Text] [Related]
4. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing.
Liu T; Sun H; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y; Sun B
Mol Cancer Ther; 2017 Jul; 16(7):1377-1388. PubMed ID: 28416606
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.
Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H
Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract][Full Text] [Related]
8. Transformer 2 alpha homolog is a downstream gene of hypoxia-inducible factor 1 subunit alpha and is involved in the progression of pancreatic cancer.
Cao W; Lei S; Zeng Z; Xiao C; Sun B; Xie P; Li Y; Luo D; Yu W
Bioengineered; 2022 May; 13(5):13238-13251. PubMed ID: 35635094
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract][Full Text] [Related]
10. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Li XL
J Cancer; 2018; 9(1):71-80. PubMed ID: 29290771
[TBL] [Abstract][Full Text] [Related]
11. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
12. TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells.
Tan Y; Hu X; Deng Y; Yuan P; Xie Y; Wang J
Brain Res Bull; 2018 Oct; 143():138-144. PubMed ID: 30367895
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression.
Xie JJ; Li WH; Li X; Ye W; Shao CF
J Biol Regul Homeost Agents; 2019; 33(2):331-343. PubMed ID: 30972996
[TBL] [Abstract][Full Text] [Related]
14. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma.
Xiao L; Wang W; Zhao J; Xu H; Li S; Yang X
Oncol Lett; 2020 Nov; 20(5):164. PubMed ID: 32934732
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
Hirata H; Hinoda Y; Shahryari V; Deng G; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
Cancer Res; 2015 Apr; 75(7):1322-31. PubMed ID: 25600645
[TBL] [Abstract][Full Text] [Related]
17. TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer's microenvironment.
Liu Q; Zhu L; Liu X; Zheng J; Liu Y; Ruan X; Cao S; Cai H; Li Z; Xue Y
RNA Biol; 2020 Sep; 17(9):1293-1308. PubMed ID: 32372707
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 regulates oxLDL-induced CD36 expression via activating β-catenin.
Huangfu N; Xu Z; Zheng W; Wang Y; Cheng J; Chen X
Biochem Biophys Res Commun; 2018 Jan; 495(3):2111-2117. PubMed ID: 29258822
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
